Literature DB >> 34100729

Integrative analysis reveals essential mRNA, long non-coding RNA (lncRNA), and circular RNA (circRNA) in paroxysmal and persistent atrial fibrillation patients.

Haoliang Sun1, Junjie Zhang2, Yongfeng Shao1.   

Abstract

OBJECTIVE: This study aimed to investigate the functions of mRNA, long non-coding RNA (lncRNA), and circular RNA (circRNA) in paroxysmal and persistent atrial fibrillation (AF) patients.
METHODS: A total of 9 left atrial appendage (LAA) tissues were collected from patients with AF (ParoAF patients = 3 and PersAF patients = 3) and donors (n=3). Genes and circRNAs were identified by per kilobase per million reads (RPKM) and number of circular reads/number of mapped reads/read length (SRPBM), respectively. Differentially expressed mRNAs (DE mRNAs), lncRNAs (DE lncRNAs), and circRNAs (DE circRNAs) were identified by | log2 (Fold Change) | ≥ 2 and p-value < 0.05. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. Protein-protein, mRNA-lncRNA, and circRNA-miRNA interaction networks were constructed. In addition, logistic analysis was conducted among AF and circRNAs.
RESULTS: A total of 285 (116 up-regulated and 169 down-regulated) and 275 (110 up-regulated and 165 down-regulated) DE mRNAs, 575 (276 up-regulated and 299 down-regulated) and 583 (330 up-regulated and 253 down-regulated) DE lncRNAs, and 83 (48 up-regulated and 35 down-regulated) and 99 (58 up-regulated and 41 down-regulated) circRNAs were detected in ParoAF and PersAF, respectively, as compared with control. MAPK signal pathway as well as voltage-dependent, L type, and alpha 1C subunit calcium channel (CACNA1C) might participate in AF occurrence by preventing atrial parasympathetic remodeling. Collagen type I alpha 1 (COL1A1) and COL1A2 mostly participated in the enriched GO and KEGG terms and connected with most of the DE mRNAs. The expression of chr10: 69902697|69948883 was a protective factor against PersAF after adjusting for age (p=0.022, 95% CI: 0.003-0.634).
CONCLUSION: We found that some mRNAs, lncRNAs, circRNAs, and pathways play essential roles in AF pathogenesis and development. Moreover, one protective factor against PersAF was detected.

Entities:  

Year:  2021        PMID: 34100729      PMCID: PMC8210924          DOI: 10.14744/AnatolJCardiol.2020.57295

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


  41 in total

Review 1.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms.

Authors:  Jason Andrade; Paul Khairy; Dobromir Dobrev; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

2.  Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.

Authors:  Moritz F Sinner; Nathan R Tucker; Kathryn L Lunetta; Kouichi Ozaki; J Gustav Smith; Stella Trompet; Joshua C Bis; Honghuang Lin; Mina K Chung; Jonas B Nielsen; Steven A Lubitz; Bouwe P Krijthe; Jared W Magnani; Jiangchuan Ye; Michael H Gollob; Tatsuhiko Tsunoda; Martina Müller-Nurasyid; Peter Lichtner; Annette Peters; Elena Dolmatova; Michiaki Kubo; Jonathan D Smith; Bruce M Psaty; Nicholas L Smith; J Wouter Jukema; Daniel I Chasman; Christine M Albert; Yusuke Ebana; Tetsushi Furukawa; Peter W Macfarlane; Tamara B Harris; Dawood Darbar; Marcus Dörr; Anders G Holst; Jesper H Svendsen; Albert Hofman; Andre G Uitterlinden; Vilmundur Gudnason; Mitsuaki Isobe; Rainer Malik; Martin Dichgans; Jonathan Rosand; David R Van Wagoner; Emelia J Benjamin; David J Milan; Olle Melander; Susan R Heckbert; Ian Ford; Yongmei Liu; John Barnard; Morten S Olesen; Bruno H C Stricker; Toshihiro Tanaka; Stefan Kääb; Patrick T Ellinor
Journal:  Circulation       Date:  2014-08-14       Impact factor: 29.690

Review 3.  Circular RNA and its mechanisms in disease: From the bench to the clinic.

Authors:  Bing Han; Jie Chao; Honghong Yao
Journal:  Pharmacol Ther       Date:  2018-02-14       Impact factor: 12.310

4.  Long non‑coding RNA AK055347 is upregulated in patients with atrial fibrillation and regulates mitochondrial energy production in myocardiocytes.

Authors:  Guiying Chen; Hong Guo; Ying Song; Huiying Chang; Shaojun Wang; Miaomiao Zhang; Chang Liu
Journal:  Mol Med Rep       Date:  2016-10-26       Impact factor: 2.952

5.  Long-Term Results of Surgical Atrial Fibrillation Radiofrequency Ablation: Comparison of Two Methods.

Authors:  Song Yang; Bo Mei; Kangni Feng; Weibin Lin; Guangxian Chen; Mengya Liang; Xi Zhang; Zhongkai Wu
Journal:  Heart Lung Circ       Date:  2017-05-24       Impact factor: 2.975

6.  Long non-coding RNA expression profile in atrial fibrillation.

Authors:  Zhongbao Ruan; Xiaohua Sun; Haihui Sheng; Li Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  c-Ski, Smurf2, and Arkadia as regulators of TGF-beta signaling: new targets for managing myofibroblast function and cardiac fibrosis.

Authors:  Ryan H Cunnington; Mansoreh Nazari; Ian M C Dixon
Journal:  Can J Physiol Pharmacol       Date:  2009-10       Impact factor: 2.273

8.  TGF-β1 signal pathway in the regulation of inflammation in patients with atrial fibrillation.

Authors:  Ye Erbo Lati Ali Mira; Wu-Hong Lu; Peng-Yi He; Zhi-Qiang Liu; Yu-Chun Yang
Journal:  Asian Pac J Trop Med       Date:  2013-12       Impact factor: 1.226

9.  Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit.

Authors:  Xuyu He; Kunyi Zhang; Xiuren Gao; Liwen Li; Hong Tan; Jiyan Chen; Yingling Zhou
Journal:  Heart Vessels       Date:  2016-03-11       Impact factor: 2.037

10.  Integrative Analysis Reveals Key Circular RNA in Atrial Fibrillation.

Authors:  Xiaofeng Hu; Linhui Chen; Shaohui Wu; Kai Xu; Weifeng Jiang; Mu Qin; Yu Zhang; Xu Liu
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

View more
  1 in total

Review 1.  Research Progress of LncRNAs in Atrial Fibrillation.

Authors:  Wenhui Wang; Bei Tian; Zhongping Ning; Xinming Li
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.